DNMT3A Co-Mutation and Real-World Clinical Outcomes With Gilteritinib in FLT3-Mutated Acute Myeloid Leukaemia Across Molecular Subgroups
{{output}}
Introduction: Molecular co-mutations modulate outcomes in FLT3-mutated AML treated with gilteritinib; real-world data stratified by DNMT3A co-mutation status are lacking. ... ...